News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Novartis AG Buys 85 Percent Stake In Chinese Vaccines Company, Zhejiang Tianyuan
March 22, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
(RTTNews) - Swiss healthcare firm Novartis AG (NVS: News ) Tuesday said it has completed the transaction to acquire an 85 percent stake in the Chinese vaccines company Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Novartis
MORE ON THIS TOPIC
Drug Development
Genmab drops 2 antibody assets, including another ProfoundBio ADC
May 15, 2026
·
2 min read
·
Gabrielle Masson
Funding
Degron adds $40M to series A, supporting immunology plans for molecular glue platform
May 14, 2026
·
2 min read
·
Tristan Manalac
Job Trends
Hiring outlook: job opportunities on
BioSpace
rise YOY, but layoffs affect thousands
May 14, 2026
·
3 min read
·
Angela Gabriel
Manufacturing
Bora inks $122.5M takeover of MacroGenics facility to further US expansion
May 13, 2026
·
2 min read
·
Nick Paul Taylor
